Global Financial Private Capital’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,667
Closed -$258K 422
2019
Q4
$258K Sell
1,667
-59
-3% -$8.5K 0.01% 237
2019
Q3
$233K Buy
+1,726
New +$226K 0.01% 241
2018
Q4
Sell
-2,716
Closed -$313K 477
2018
Q3
$313K Sell
2,716
-243
-8% -$26.6K 0.01% 443
2018
Q2
$306K Sell
2,959
-38
-1% -$3.85K 0.01% 450
2018
Q1
$295K Sell
2,997
-9,009
-75% -$851K 0.01% 448
2017
Q4
$1.02M Buy
+12,006
New +$992K 0.03% 252

Other funds holding RMD

Global Financial Private Capital's RMD Position: Q1 2020 in Review

Global Financial Private Capital sold out of ResMed (RMD) in Q1 2020, closing a stake of 1,667 shares — an estimated $258K sold.

Global Financial Private Capital first reported a position in RMD in Q4 2017 and held it in 6 quarters. The position peaked at $1.02M in Q4 2017. 585 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

  • Global Financial Private Capital reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
  • Global Financial Private Capital sold 1,667 ResMed shares in Q1 2020, an estimated $258K.
  • Global Financial Private Capital first reported a position in ResMed in Q4 2017 and held it in 6 quarters.
  • Global Financial Private Capital's ResMed position peaked at $1.02M in Q4 2017.
  • 585 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on Global Financial Private Capital's 13F filing for Q1 2020, filed 12 May 2020.